ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2026

Abstract Number: 1977

A Pro-Migratory Paradox: Methylprednisolone Dampens Cytokine Secretion yet Enhances Neutrophil Migration in Health and Systemic Lupus Erythematosus

Guangnan Hu1, Ehsan Dehdashtian1, Leah Whiteman1, Md Islam1, Stefania Gallucci1 and Roberto Caricchio2

Affiliations: 1UMass Chan Medical School, Worcester, 2University of Massachusetts Chan Medical School, Worcester, MA

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2026

Keywords: chemokines, cytokines, glucocorticoids, neutrophils, Systemic lupus erythematosus (SLE)

Session Information

Date: Tuesday, November 10, 2026

Title: (1977-1995) Systemic Lupus Erythematosus - Translational Models and Mechanisms Poster C

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Neutrophils are increasingly recognized as drivers of systemic lupus erythematosus (SLE), and glucocorticoids such as methylprednisolone (MP) are widely used to suppress inflammation. While profiling neutrophil transcriptomes in a patient with SLE undergoing CD19 chimeric antigen receptor (CAR) T-cell therapy, we observed that in vivo pulse MP produced minimal change in the disease-specific neutrophil transcriptomic signature, suggesting steroids may not broadly deactivate neutrophils. We therefore examined how MP modulates neutrophil transcription, inflammatory cytokine secretion and directed migration in healthy and SLE donors.

Methods: Neutrophils were isolated by negative selection from healthy controls (HC) and patients with SLE, including subgroups receiving anifrolumab or belimumab (Table 1). All patients with SLE met at least 4 of the 2019 EULAR/ACR classification criteria. For functional assays, neutrophils were cultured for 18 hours under four matched conditions: diluted DMSO vehicle, MP alone (22.7 µM), lipopolysaccharide (LPS) alone (100 ng/ml), or LPS plus MP; TNF, CCL3, and IL-8 were measured in supernatants, and migration toward IL-8 was assessed by 1-hour transwell assay as fold change (FC) relative to the no-chemoattractant condition. Separately, neutrophils from HC and patients with SLE were treated ex vivo with MP (22.7 µM, 2 hours) and profiled by bulk RNA sequencing. Cohorts partially overlapped.

Results: MP induced classical GC early-response genes (e.g. FKBP5, TSC22D3, KLF9, DUSP1, NFKBIA) in both HC and SLE neutrophils, confirming an intact GC transcriptional response. LPS robustly induced TNF, CCL3, and IL-8 secretion in both HC and SLE, whereas MP alone did not (Figure 1). Co-treatment with MP markedly reduced LPS-induced secretion of all three cytokines across groups. In contrast, MP increased IL-8-directed migration in every group tested (Figure 2). In HC, median migration rose from FC ~2 with vehicle to ~11 with MP; in patients with SLE, from ~1.6 to ~6.5. Neutrophils from SLE patients receiving anifrolumab or belimumab also showed MP-enhanced migration, though of lesser magnitude (median FC ~3-4). Additionally, LPS stimulation alone did not promote migration, whereas adding MP to LPS increased it in HC and patients with SLE.

Conclusion: MP engaged the classical GC transcriptional program in neutrophils and suppressed LPS-induced inflammatory cytokine secretion, the expected glucocorticoid response, yet paradoxically enhanced directed migration, in both healthy individuals and patients with SLE. Rather than broadly deactivating neutrophils, MP appears to reprogram them, dampening cytokine output while priming a pro-migratory phenotype. These findings have potential implications for infection risk and tissue injury during steroid therapy in SLE.

Supporting image 1Table 1. Demographic and clinical characteristics of study participants. Values are median (Q1, Q3), number, or percentage, as indicated.

Supporting image 2Figure 1. Methylprednisolone suppresses LPS-induced neutrophil cytokine secretion. Neutrophils from healthy controls (HC), patients with SLE, and an anifrolumab-treated SLE subgroup (SLE.Anifrolumab) were cultured for 18 hours with diluted DMSO vehicle, methylprednisolone alone (MP, 22.7 µM), lipopolysaccharide alone (LPS, 100 ng/ml), or LPS plus MP (MP_LPS). Concentrations of (A) IL-8, (B) CCL3, and (C) TNF were measured in culture supernatants (pg/ml). Boxes show the median and interquartile range.

Supporting image 3Figure 2. Methylprednisolone enhances IL-8-directed neutrophil migration in health and SLE. Neutrophils were isolated by negative selection from healthy controls (HC) and patients with systemic lupus erythematosus (SLE), including subgroups receiving anifrolumab (SLE.Anifrolumab) or belimumab (SLE.Belimumab), and cultured for 18 hours with diluted DMSO vehicle, methylprednisolone alone (MP, 22.7 µM), lipopolysaccharide alone (LPS, 100 ng/ml), or LPS plus MP (MP_LPS). Cells were then assessed for migration toward IL-8 in a 1-hour transwell assay. Migration is expressed as fold change (FC) relative to the no-chemoattractant condition (no_IL8, FC = 1). Boxes show the median and interquartile range.


Disclosures: G. Hu: None; E. Dehdashtian: None; L. Whiteman: None; M. Islam: None; S. Gallucci: None; R. Caricchio: None.

To cite this abstract in AMA style:

Hu G, Dehdashtian E, Whiteman L, Islam M, Gallucci S, Caricchio R. A Pro-Migratory Paradox: Methylprednisolone Dampens Cytokine Secretion yet Enhances Neutrophil Migration in Health and Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 9). https://acrabstracts.org/abstract/a-pro-migratory-paradox-methylprednisolone-dampens-cytokine-secretion-yet-enhances-neutrophil-migration-in-health-and-systemic-lupus-erythematosus/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-pro-migratory-paradox-methylprednisolone-dampens-cytokine-secretion-yet-enhances-neutrophil-migration-in-health-and-systemic-lupus-erythematosus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology